SAN FRANCISCO — In this Healio Video Perspective from the AAO meeting, Preeya K. Gupta, MD, discusses the potential of the SpyGlass Pharma IOL and bimatoprost delivery platform for lowering IOP long-term.
“A new product that is under investigation by SpyGlass is a new intraocular lens with a drug-delivery system that will deliver bimatoprost for 3 years in patients who require intraocular pressure control,” Gupta said.